Back to search

Tamoxifen and Breast Cancer Incidence Among Women With Inherited Mutations in BRCA1 and BRCA2

Data up to Jan 2025

Published2001
Citations750
References36

Total Citations Per Year

Abstract

References (36)

Base-Calling of Automated Sequencer Traces UsingPhred. I. Accuracy Assessment

1998 • 6,925 citations

A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1

1994 • 5,994 citations

Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1998 • 5,487 citations

Base-Calling of Automated Sequencer Traces Using Phred. II. Error Probabilities

1998 • 5,382 citations

Tamoxifen for early breast cancer: an overview of the randomised trials

1998 • 4,082 citations

Identification of the breast cancer susceptibility gene BRCA2

1995 • 3,581 citations

Consed: A Graphical Tool for Sequence Finishing

1998 • 3,325 citations

Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually

1989 • 3,239 citations

Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21

1990 • 2,505 citations

Cancer Risks in BRCA2 Mutation Carriers

1999 • 1,477 citations

A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors

1989 • 1,471 citations

PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing

1997 • 946 citations

Breast Cancer after Prophylactic Bilateral Mastectomy in Women with aBRCA1orBRCA2Mutation

2001 • 945 citations

Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients With Early-Onset Breast Cancer

1999 • 866 citations

Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast Cancer

1999 • 676 citations

Breast Cancer Risk After Bilateral Prophylactic Oophorectomy in BRCA1 Mutation Carriers

1999 • 674 citations

BRCA1 and BRCA2 and the genetics of breast and ovarian cancer

2001 • 626 citations

Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases

1997 • 580 citations

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study

2000 • 536 citations

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1

1998 • 453 citations

Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer

1999 • 390 citations

Frequency of Breast Cancer Attributable to <EMPH TYPE="ITAL">BRCA1</EMPH> in a Population-Based Series of American Women

1998 • 350 citations

Tumour biological features of BRCA1-induced breast and ovarian cancer

1997 • 346 citations

BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer

2000 • 311 citations

BRCA-associated breast cancer in young women.

1998 • 309 citations

Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1.

1996 • 272 citations

Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study.

1999 • 229 citations

Frequency ofBRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases

2000 • 207 citations

Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes

1998 • 185 citations

Survival in Hereditary Breast Cancer Associated With Germline Mutations of BRCA2

1999 • 183 citations

Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women

1997 • 177 citations

BRCA1-related breast cancer in Austrian breast and ovarian cancer families: SpecificBRCA1 mutations and pathological characteristics

1998 • 98 citations

Breast Carcinomas Arising in Carriers of Mutations in BRCA1 or BRCA2: Are They Prognostically Different?

1999 • 95 citations

BRCA1 1675delA and 1135insA Account for One Third of Norwegian Familial Breast-Ovarian Cancer and Are Associated with Later Disease Onset than Less Frequent Mutations

1999 • 31 citations

SeqHelp: A Program to Analyze Molecular Sequences Utilizing Common Computational Resources

1998 • 28 citations

Incidence of BRCA1/2 germ line alterations in a high risk cohort participating in a phase II chemoprevention trial

2000 • 6 citations

Cited By (0)

No citing papers found in database

Tamoxifen and Breast Cancer Incidence Among Women With Inherited Mutations in BRCA1 and… (2001) – JAMA | Metascience Observatory Explorer